🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jason Fangusaro

Emory University

ORCID: 0000-0003-3099-5259
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium”.

Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium

American Journal of Neuroradiology(2020)10.3174/ajnr.a6499
N/A
0DataRank · unranked
27 citations

Douglas L. Brown, Catherine A. Billups, Zoltán Patay, Gilbert Vézina, Mark S. Shiroishi +7 more

A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study

Neuro-Oncology(2021)10.1093/neuonc/noab047
N/A
0DataRank · unranked
159 citations

Arzu Onar‐Thomas, Tina Young Poussaint, Shengjie Wu, Azra H. Ligon, Neal I. Lindeman +18 more

Clinical activity of MAPK targeted therapies in patients with non-V600 BRAF mutant tumors

medRxiv(2022)10.1101/2022.02.17.22271120
N/A
0DataRank · unranked
1 citations

Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A. Nebhan, Ibiayi Dagogo‐Jack +24 more

Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)

Neuro-Oncology(2023)10.1093/neuonc/noad141
N/A
0DataRank · unranked
64 citations

Tabitha Cooney, John Glod, Jie Huang, Cody J. Peer, Damien Faury +14 more

Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30600
N/A
0DataRank · unranked
12 citations

Arzu Onar‐Thomas, Jason Fangusaro, Nicholas G. Gottardo, Kenneth J. Cohen, Amy Smith +4 more

Towards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation

Neuro-Oncology(2024)10.1093/neuonc/noae093
N/A
0DataRank · unranked
25 citations

Anahita Fathi Kazerooni, Arastoo Vossough, Jeffrey B. Ware, Sina Bagheri, Nastaran Khalili +16 more

Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3386
N/A
0DataRank · unranked
12 citations

Robert A. Avery, Michael J. Fisher, Roger J. Packer, Karin S. Walsh, Antoinette Y. N. Schouten‐van Meeteren +8 more

A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4

Neuro-Oncology(2025)10.1093/neuonc/noaf065
N/A
0DataRank · unranked
13 citations

Arzu Onar‐Thomas, Tina Young Poussaint, Shelly Lensing, Azra H. Ligon, Neal Lindeman +14 more

Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report

Neuro-Oncology(2025)10.1093/neuonc/noaf118
N/A
0DataRank · unranked
8 citations

Michael A. Vogelbaum, Timothy F. Cloughesy, Norbert Galldiks, Nathalie L. Albert, Joerg-Christian Tonn +30 more

Head-to-head preclinical treatment design prioritizes promising therapies for neurofibromatosis type 1 optic glioma clinical translation

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf215
N/A
0DataRank · unranked
1 citations

Jit Chatterjee, Shintaro Yamada, Anthony Kirchner, Hareesh B. Nair, Jason Fangusaro +2 more

Neurocognitive outcomes following 30.6-Gy whole-ventricular radiotherapy with 54-Gy total dose focal tumor bed boost for CNS non-germinomatous germ cell tumors: A Children’s Oncology Group study (ACNS1123).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.10036
N/A
0DataRank · unranked
0 citations

Yu Wang, Christine L. Trask, Arzu Onar‐Thomas, Jason Fangusaro, Ute Bartels +3 more